These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 32260444)

  • 41. The mucopolysaccharidoses: a synergism between clinical and basic investigation.
    Fluharty AL
    J Invest Dermatol; 1982 Jul; 79 Suppl 1():38s-44s. PubMed ID: 6806398
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pathogenesis of skeletal and connective tissue involvement in the mucopolysaccharidoses: glycosaminoglycan storage is merely the instigator.
    Clarke LA
    Rheumatology (Oxford); 2011 Dec; 50 Suppl 5():v13-8. PubMed ID: 22210665
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The rapidly evolving view of lysosomal storage diseases.
    Parenti G; Medina DL; Ballabio A
    EMBO Mol Med; 2021 Feb; 13(2):e12836. PubMed ID: 33459519
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathogenesis and treatment of spine disease in the mucopolysaccharidoses.
    Peck SH; Casal ML; Malhotra NR; Ficicioglu C; Smith LJ
    Mol Genet Metab; 2016 Aug; 118(4):232-43. PubMed ID: 27296532
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quantitative neuroimaging in mucopolysaccharidoses clinical trials.
    Nestrasil I; Vedolin L
    Mol Genet Metab; 2017 Dec; 122S():17-24. PubMed ID: 29111092
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surgical management of neurological manifestations of mucopolysaccharidosis disorders.
    Alden TD; Amartino H; Dalla Corte A; Lampe C; Harmatz PR; Vedolin L
    Mol Genet Metab; 2017 Dec; 122S():41-48. PubMed ID: 29153846
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biomarkers for the mucopolysaccharidoses: discovery and clinical utility.
    Clarke LA; Winchester B; Giugliani R; Tylki-Szymańska A; Amartino H
    Mol Genet Metab; 2012 Aug; 106(4):395-402. PubMed ID: 22658917
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hepatic storage of glycosaminoglycans in feline and canine models of mucopolysaccharidoses I, VI, and VII.
    Haskins ME; Otis EJ; Hayden JE; Jezyk PF; Stramm L
    Vet Pathol; 1992 Mar; 29(2):112-9. PubMed ID: 1632054
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Current and new therapies for mucopolysaccharidoses.
    Penon-Portmann M; Blair DR; Harmatz P
    Pediatr Neonatol; 2023 Feb; 64 Suppl 1():S10-S17. PubMed ID: 36464587
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Bone Biomarkers in Mucopolysaccharidoses.
    Nakamura-Utsunomiya A
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884458
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Enzymatic Degradation of Heparan Sulfate.
    Griffin LS; Gloster TM
    Protein Pept Lett; 2017; 24(8):710-722. PubMed ID: 28741461
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Advances in the Development of Pharmacological Chaperones for the Mucopolysaccharidoses.
    Losada Díaz JC; Cepeda Del Castillo J; Rodriguez-López EA; Alméciga-Díaz CJ
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31905715
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Different serum enzyme levels are required to rescue the various systemic features of the mucopolysaccharidoses.
    Cotugno G; Tessitore A; Capalbo A; Annunziata P; Strisciuglio C; Faella A; Aurilio M; Di Tommaso M; Russo F; Mancini A; De Leonibus E; Aloj L; Auricchio A
    Hum Gene Ther; 2010 May; 21(5):555-69. PubMed ID: 20021231
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Separation of sulfated urinary glycosaminoglycans by high-resolution electrophoresis for isotyping of mucopolysaccharidoses in Malaysia.
    Nor A; Zabedah MY; Norsiah MD; Ngu LH; Suhaila AR
    Malays J Pathol; 2010 Jun; 32(1):35-42. PubMed ID: 20614724
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pain in Mucopolysaccharidoses: Analysis of the Problem and Possible Treatments.
    Congedi S; Orzalesi M; Di Pede C; Benini F
    Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30297617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genistein-mediated inhibition of glycosaminoglycan synthesis, which corrects storage in cells of patients suffering from mucopolysaccharidoses, acts by influencing an epidermal growth factor-dependent pathway.
    Jakóbkiewicz-Banecka J; Piotrowska E; Narajczyk M; Barańska S; Wegrzyn G
    J Biomed Sci; 2009 Mar; 16(1):26. PubMed ID: 19272193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glycosaminoglycan storage disorders: a review.
    Coutinho MF; Lacerda L; Alves S
    Biochem Res Int; 2012; 2012():471325. PubMed ID: 22013531
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mucopolysaccharidoses and the eye.
    Ashworth JL; Biswas S; Wraith E; Lloyd IC
    Surv Ophthalmol; 2006; 51(1):1-17. PubMed ID: 16414358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Failures of Endochondral Ossification in the Mucopolysaccharidoses.
    Jiang Z; Byers S; Casal ML; Smith LJ
    Curr Osteoporos Rep; 2020 Dec; 18(6):759-773. PubMed ID: 33064251
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular characteristics of patients with glycosaminoglycan storage disorders in Russia.
    Chistiakov DA; Savost'anov KV; Kuzenkova LM; Gevorkyan AK; Pushkov AA; Nikitin AG; Pakhomov AV; Vashakmadze ND; Zhurkova NV; Podkletnova TV; Mayansky NA; Namazova-Baranova LS; Baranov AA
    Clin Chim Acta; 2014 Sep; 436():112-20. PubMed ID: 24875751
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.